- Home
- SBSI vs NEO Comparison
SBSI vs NEO Comparison
Compare SBSI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBSI | NEO |
|---|---|---|
| Founded | 1960 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 972.0M | 1.0B |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SBSI | NEO |
|---|---|---|
| Price | $32.41 | $8.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $35.33 | $13.38 |
| AVG Volume (30 Days) | 67.7K | ★ 2.1M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.87 | $10.63 |
| Revenue Next Year | $5.82 | $9.73 |
| P/E Ratio | $41.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.32 | $4.72 |
| 52 Week High | $34.53 | $13.74 |
Technical Indicators
Market Signals| Indicator | SBSI | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 54.27 |
| Support Level | $31.82 | $8.68 |
| Resistance Level | $33.82 | $8.84 |
| Average True Range (ATR) | 0.88 | 0.43 |
| MACD | -0.16 | -0.04 |
| Stochastic Oscillator | 36.36 | 41.77 |
Price Performance
Historical ComparisonAbout SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.